Figure 1
![Figure 1. Elevation of plasma L5 concentration in patients with STEMI. Fast-protein liquid chromatography analysis of LDL showing the content of each subfraction (L1-L5) in (A) normal control subjects with no cardiovascular risk factors and (B) patients with STEMI. The (C) L5% and (D) L5 plasma concentration ([L5]) for each subject is plotted. The line represents the mean of the group. The mean [L5] was significantly higher in STEMI patients (n = 30) than in control subjects (n = 30). ***P < .001, determined by using the Wilcoxon rank-sum test.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/122/22/10.1182_blood-2013-05-504639/4/3632f1.jpeg?Expires=1735579940&Signature=zkovsCgF81~03nUyuZ9UwBTZcxdKG-oZqdtthdNjkDNRiUSN4tCieMyX-H0XmE8O-Q9ABXw9gnRWFQ8XWUlOmfjlgZYDYiulUBJAgRJqcmkG12XmaoOYsw7P63cWb13TFECCWHMNHGf~gt35aJbSXaTwb3C1B9FAIyRmOFMzMFUXK1pIxL89ItxY5Uwp7f4CmY3b2XAu8oVGxMfhoF~wxAhVSW4QTnjATqWlf~oUNIF9JZGn3IifeM6InjZ3THQYD1icuf61LhlZ8ZIonPNFPio2bgWdtRO~QcGBIBylbYXj6sgv3xHQd1EwNG8y7M~Uyf~MIwzEYsQDtngM1i5xew__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Elevation of plasma L5 concentration in patients with STEMI. Fast-protein liquid chromatography analysis of LDL showing the content of each subfraction (L1-L5) in (A) normal control subjects with no cardiovascular risk factors and (B) patients with STEMI. The (C) L5% and (D) L5 plasma concentration ([L5]) for each subject is plotted. The line represents the mean of the group. The mean [L5] was significantly higher in STEMI patients (n = 30) than in control subjects (n = 30). ***P < .001, determined by using the Wilcoxon rank-sum test.
